PrecisionCardio™
Industry alliance for
precision cardiovascular medicine
PrecisionCardioIndustry Alliance

Precision cardiovascular medicine now has an industry alliance.

PrecisionCardio™ brings therapeutics companies together, across the diseases hiding beneath familiar cardiovascular presentations, to translate precision into practice.

Start a conversationStart a membership conversation
An independent nonprofit industry association

01Our working definition

What is precision cardiovascular medicine?

Looking beyond the presenting diagnosis to identify the specific disease, mechanism, or cause driving it. A more precise diagnosis can change what happens next: risk assessment, treatment, surveillance, and care for families.

Heart failure is not one disease. Neither are many of the broad labels used across cardiovascular medicine.

A broad cardiovascular label drawn hollow, with the diseases it can contain set inside it

02What PrecisionCardio is

Cardiovascular disease is the world's number one killer.We are united to dethrone it.

Our mission

Help more patients reach a precise diagnosis and disease-specific care, sooner.

WhatA nonprofit association.

Independent and member-governed.

WhoBiotech and pharma.

Therapeutics companies working across precision cardiovascular medicine.

HowPre-competitive collective action.

Members set the priorities and work together on shared, disease-level challenges.

Incorporated in Delaware. Seeking recognition under Section 501(c)(6).

03From presentation to precision

Every step has to connect.

Recognizing the clue is only the beginning. Reaching an etiologic diagnosis depends on the right characterization, testing, interpretation and integration.

Recognize

Clinical clues

Characterize

Phenotype

Test

Disease-directed testing

Interpret

Results in context

Diagnose

Etiologic diagnosis

Act

Disease-specific management

04Why an industry alliance

The science differs.The barriers repeat.

Different diseases require different workups.
When a necessary step is missed, the path to a precise diagnosis can stop.

Illustrative points of failure, not disease-specific claims

No therapy can help a patient who was never diagnosed.

Recurring barriers create opportunities no single company can address alone.

05The boundary

At the disease level, the challenge is shared. Product-specific decisions are not.

PrecisionCardio works on shared, disease-level questions. Product-specific development decisions, product and commercial strategy, pricing, contracting, and other competitively sensitive matters remain with each company. Educational and scientific content is developed independently of member companies.

06How it works

Members set the agenda.

Members set the direction and help lead it. Dues fund the team that carries the work out. Membership is for therapeutics companies; advocacy groups, societies and clinical experts partner project by project.

Step 01Members share what they are seeing.
Step 02Members choose the priority.
Step 03Members lead the work.

Improving use of disease-directed testing

A working group forms: members and relevant external expertise

Member-led working groups Clear pre-competitive boundaries Partnerships beyond PrecisionCardio

07Membership

Built by the companies shaping the field.

PrecisionCardio is building its founding membership now. Founding members will help define PrecisionCardio's first agenda and shape how the field works together from the start.

Founding membershipNow forming · Open through December 2026

Founding leadership

A Board of Directors is forming with the founding membership.